AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
Traws Pharma, Inc. Common Stock
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG001T921M7
0.34▼ 0.02 (-6.60%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
0.37
Day's Range
0.33 – 0.35
52-Week Range
0.33 – 3.23
Volume
105.4K
Avg Volume
1.1M
Share Statistics
Shares Outstanding
Employees
7
Exchange
XNAS
Listed
2013-07-25
Share count as of August 12, 2026

Traws Pharma, Inc. Common Stock (TRAW) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly

No financial data found for TRAW

Try a different ticker. We may not have processed this company's filings yet.

Key questions about Traws Pharma, Inc. Common Stock (TRAW)
What is Traws Pharma, Inc. Common Stock's Market Cap?
Traws Pharma, Inc. Common Stock's Market Cap is $5.3M, based on as-reported figures from SEC (XBRL) filings.
What is Traws Pharma, Inc. Common Stock's Enterprise Value?
Traws Pharma, Inc. Common Stock's Enterprise Value is $247.6K, based on as-reported figures from SEC (XBRL) filings.
What is Traws Pharma, Inc. Common Stock's Price / Sales?
Traws Pharma, Inc. Common Stock's Price / Sales is 1.9×, based on as-reported figures from SEC (XBRL) filings.
What is Traws Pharma, Inc. Common Stock's EV / Revenue?
Traws Pharma, Inc. Common Stock's EV / Revenue is 0.1×, based on as-reported figures from SEC (XBRL) filings.
What is Traws Pharma, Inc. Common Stock's EV / EBITDA?
Traws Pharma, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Traws Pharma, Inc. Common Stock's Revenue (TTM)?
Traws Pharma, Inc. Common Stock's Revenue (TTM) is $2.8M, based on as-reported figures from SEC (XBRL) filings.
What is Traws Pharma, Inc. Common Stock's Net Income (TTM)?
Traws Pharma, Inc. Common Stock's Net Income (TTM) is -$21.6M, based on as-reported figures from SEC (XBRL) filings.
What is Traws Pharma, Inc. Common Stock's EBITDA?
Traws Pharma, Inc. Common Stock's EBITDA is -$21.4M, based on as-reported figures from SEC (XBRL) filings.
What is Traws Pharma, Inc. Common Stock's Diluted EPS (TTM)?
Traws Pharma, Inc. Common Stock's Diluted EPS (TTM) is -1.40, based on as-reported figures from SEC (XBRL) filings.
What is Traws Pharma, Inc. Common Stock's EBITDA Margin?
Traws Pharma, Inc. Common Stock's EBITDA Margin is -766.9%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · TRAWAs-filed SEC (XBRL) data